title: Letter from the editor.
authors.affiliation: Senior Vice President R&D and Chief Technology Officer; NasVax, Ltd.; Ness Ziona, Israel.
authors.forename: Ronald
authors.initials: R
authors.lastname: Ellis
authors.affiliation: Acquisitions Editor; Landes Bioscience; Vienna, Austria.
authors.forename: Eva M
authors.initials: EM
authors.lastname: Riedmann
mesh_terms: D055808:Drug Discovery / Q000639:trends*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D019444:Vaccines, DNA / Q000008:administration & dosage* / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification
chemical_list: D019444:Vaccines, DNA